Search results
Results from the WOW.Com Content Network
In 2014, IBA Group joined the International Association of Outsourcing Professionals (IAOP). [13] In 2015, IBA Group opened an office in Bratislava, Slovakia. [14] In 2017, IBA CZ moved to a new office in Prague. [15] In the same year, IBA Group opened a development center in Bulgaria. [16] In 2018, IBA Group joined the UN Global Compact ...
IBA has developed an affinity chromatography system for non-magnetic isolation of peripheral blood mononuclear cells, T cells, B cells and other cells of interest. This technology is known as Fab-TACS (Traceless Affinity Cell Selection) and is based on Strep-tagged Fab fragments, which reversibly capture and release the target cells.
IBA (Ion Beam Applications SA) is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain (UCLouvain) and became a university spin-off. It employs about 1500 people in 40 locations. [1]
BTG Limited is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The current name was adopted when the British Technology Group changed its name on 27 May 1998. [2]
In February 2015, AMRI acquired SSCI based in West Lafayette, Indiana. SSCI was founded in 1991, providing comprehensive cGMP solid state chemistry research and analytical services to the pharmaceutical industry. Servicing more than 250 customers a year. [25] [26] In July 2015, the company acquired Gadea Pharmaceutical group for $174 million. [27]
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
The pharmaceutical industry is a medical industry that discovers, develops, produces and markets pharmaceutical goods. These medications are are then administered to (or self-administered by) patients for curing or prevention of disease , as well as alleviating symptoms of illness or injury .
2015: ICON acquired MediMedia Pharma Solutions to enhance market access and scientific communications capabilities, and PMG Research Inc., an integrated network of clinical research sites in the US [37] [38] 2016: ICON acquired Clinical Research Management Inc., to extend its presence in the government-sponsored research market [39]